Tapewire

Nasdaq · USD

PLYX

Polaryx Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6769
SEC CIK
0002075320
Parsed reports
9

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 27, 2026 Filed May 29, 2026 00:00 UTC
Yang Alex Keun MoDirector · Chief Executive Officer · 10% owner
Mstone Partners Healthcare LtdDirector · 10% owner
PurchaseCommon Stock 88,453 $4.07 $360,003.71
Disclosure

SEC source: 0001213900-26-062322 · ownership.xml · nonDerivative · entry 1

Yang Alex Keun Mo · CIK 0002103399 · Director · Chief Executive Officer · 10% owner

Mstone Partners Healthcare Ltd · CIK 0002104809 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mstone Partners Healthcare Limited

Disclosed balance after: 24,233,249

F1 · shares: As disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on May 28, 2026, MStone Partners Healthcare Limited ("Mstone") purchased 88,453 shares of common stock in a private placement transaction, for gross proceeds to the Issuer of $360,000.

F2 · ownership.nature: Alex Keun Mo Yang is the founder and Chief Executive Officer of Mstone. Mr. Yang disclaims beneficial ownership over any of the reported securities, except to the extent of his pecuniary interest therein.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 16:41 UTC
Landis G. MichaelDirector · Chief Financial Officer
PurchaseCommon Stock 2,867 $2.79 $7,990.62
Disclosure

SEC source: 0001213900-26-018845 · ownership.xml · nonDerivative · entry 1

Landis G. Michael · CIK 0001548560 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 228,225

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.